Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,001 | 4,615 | 4,499 | 24,470 | 17,116 |
| Depreciation Amortization | 860 | 416 | 155 | 314 | 203 |
| Income taxes - deferred | -265 | -177 | -88 | 175 | 200 |
| Accounts receivable | 5,472 | 7,369 | 1,315 | -2,547 | -1,250 |
| Other Working Capital | 4,615 | 9,271 | 3,135 | -3,539 | -3,501 |
| Other Operating Activity | -4,241 | -6,668 | -796 | 3,412 | 1,771 |
| Operating Cash Flow | $16,443 | $14,826 | $8,220 | $22,285 | $14,538 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,148 | -2,533 | 6,206 | -32,034 | -16,722 |
| PPE Investments | -70 | -70 | -70 | N/A | N/A |
| Investing Cash Flow | $-18,217 | $-2,603 | $6,136 | $-32,034 | $-16,722 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62 | 62 | N/A | 2,192 | 2,133 |
| Common Stock Repurchased | -413 | -413 | -221 | -621 | -357 |
| Financing Cash Flow | $-351 | $-351 | $-221 | $1,571 | $1,776 |
| Beginning Cash Position | 4,999 | 4,999 | 4,999 | 13,177 | 13,177 |
| End Cash Position | 2,874 | 16,872 | 19,134 | 4,999 | 12,769 |
| Net Cash Flow | $-2,126 | $11,872 | $14,135 | $-8,177 | $-407 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,443 | 14,826 | 8,220 | 22,285 | 14,538 |
| Capital Expenditure | -70 | -70 | -70 | N/A | N/A |
| Free Cash Flow | 16,373 | 14,757 | 8,151 | 22,285 | 14,538 |